Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lisinopril Patent Expiration

Lisinopril is Used for treating acute myocardial infarction, hypertension, and heart failure. It was first introduced by Merck Research Laboratories Div Merck Co Inc in its drug Prinivil on Dec 29, 1987. Other drugs containing Lisinopril are Qbrelis, Zestril. 20 different companies have introduced drugs containing Lisinopril.


Lisinopril Patents

Given below is the list of patents protecting Lisinopril, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Qbrelis US10039800 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10265370 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10406199 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US10940177 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US11179434 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US11771733 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US12128083 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US12186360 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9463183 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9616096 Lisinopril formulations Nov 06, 2035 Azurity
Qbrelis US9814751 Lisinopril formulations Nov 06, 2035 Azurity



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Lisinopril's patents.

Given below is the list recent legal activities going on the following patents of Lisinopril.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 11 Apr, 2024 US9463183
Patent Issue Date Used in PTA Calculation
Critical
 03 Oct, 2023 US11771733
Mail Patent eGrant Notification 03 Oct, 2023 US11771733
Recordation of Patent Grant Mailed
Critical
 03 Oct, 2023 US11771733
Email Notification
Critical
 03 Oct, 2023 US11771733
Recordation of Patent eGrant 03 Oct, 2023 US11771733
Patent eGrant Notification 03 Oct, 2023 US11771733
Email Notification
Critical
 15 Sep, 2023 US11771733
Issue Notification Mailed
Critical
 13 Sep, 2023 US11771733
Dispatch to FDC 24 Aug, 2023 US11771733


Lisinopril's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lisinopril Generic API Manufacturers

Several generic applications have been filed for Lisinopril. The first generic version for Lisinopril was by Heritage Pharma Labs Inc and was approved on Jul 1, 2002. And the latest generic version is by Sciegen Pharmaceuticals Inc and was approved on Mar 4, 2021.

Given below is the list of companies who have filed for Lisinopril generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
20MG

tablet Discontinued ORAL N/A Jul 30, 2013
2.5MG

tablet Discontinued ORAL N/A Jul 30, 2013
30MG

tablet Discontinued ORAL N/A Jul 30, 2013
5MG

tablet Discontinued ORAL N/A Jul 30, 2013
10MG

tablet Discontinued ORAL N/A Jul 30, 2013
40MG

tablet Discontinued ORAL N/A Jul 30, 2013





2. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Jul 1, 2002
10MG

tablet Prescription ORAL AB Jul 1, 2002
20MG

tablet Prescription ORAL AB Jul 1, 2002
30MG

tablet Prescription ORAL AB Jul 1, 2002
40MG

tablet Prescription ORAL AB Jul 1, 2002
5MG

tablet Prescription ORAL AB Jul 1, 2002





3. AUROBINDO

Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Aurobindo.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG

tablet Prescription ORAL AB Feb 22, 2006
2.5MG

tablet Prescription ORAL AB Feb 22, 2006
10MG

tablet Prescription ORAL AB Feb 22, 2006
20MG

tablet Prescription ORAL AB Feb 22, 2006
30MG

tablet Prescription ORAL AB Feb 22, 2006
40MG

tablet Prescription ORAL AB Feb 22, 2006


Manufacturing Plant Locations
New

Aurobindo's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo as present at those locations.

Country City Firm Name
India
Bachupally Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





4. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Jul 1, 2002
5MG

tablet Prescription ORAL AB Jul 1, 2002
10MG

tablet Prescription ORAL AB Jul 1, 2002
20MG

tablet Prescription ORAL AB Jul 1, 2002
30MG

tablet Prescription ORAL AB Jul 1, 2002
40MG

tablet Prescription ORAL AB Jul 1, 2002





5. COREPHARMA

Corepharma Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Sep 30, 2002
40MG

tablet Prescription ORAL AB Sep 30, 2002
30MG

tablet Prescription ORAL AB Sep 30, 2002
20MG

tablet Prescription ORAL AB Sep 30, 2002
10MG

tablet Prescription ORAL AB Sep 30, 2002
5MG

tablet Prescription ORAL AB Sep 30, 2002


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





6. HERITAGE PHARMA

Heritage Pharma Labs Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Heritage Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG

tablet Discontinued ORAL N/A Jul 1, 2002
40MG

tablet Discontinued ORAL N/A Jul 1, 2002
2.5MG

tablet Discontinued ORAL N/A Jul 1, 2002
5MG

tablet Discontinued ORAL N/A Jul 1, 2002
10MG

tablet Discontinued ORAL N/A Jul 1, 2002
20MG

tablet Discontinued ORAL N/A Jul 1, 2002


Manufacturing Plant Locations
New

Heritage Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Heritage Pharmaceuticals Inc
East Brunswick Heritage Pharmaceuticals, Inc. DBA AVET Pharmaceutical LABS





7. HIKMA INTL PHARMS

Hikma International Pharmaceuticals Llc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Hikma Intl Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Discontinued ORAL N/A Jul 1, 2002
5MG

tablet Discontinued ORAL N/A Jul 1, 2002
10MG

tablet Discontinued ORAL N/A Jul 1, 2002
20MG

tablet Discontinued ORAL N/A Jul 1, 2002
40MG

tablet Discontinued ORAL N/A Jul 1, 2002
30MG

tablet Discontinued ORAL N/A Jun 27, 2003





8. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG

tablet Prescription ORAL AB Oct 29, 2013
2.5MG

tablet Prescription ORAL AB Oct 29, 2013
5MG

tablet Prescription ORAL AB Oct 29, 2013
10MG

tablet Prescription ORAL AB Oct 29, 2013
20MG

tablet Prescription ORAL AB Oct 29, 2013
40MG

tablet Prescription ORAL AB Oct 29, 2013





9. LUPIN

Lupin Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
30MG

tablet Prescription ORAL AB Sep 9, 2005
2.5MG

tablet Prescription ORAL AB Sep 9, 2005
5MG

tablet Prescription ORAL AB Sep 9, 2005
10MG

tablet Prescription ORAL AB Sep 9, 2005
20MG

tablet Prescription ORAL AB Sep 9, 2005
40MG

tablet Prescription ORAL AB Sep 9, 2005


Manufacturing Plant Locations
New

Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.

Country City Firm Name
India
Dabhasa LUPIN MANUFACTURING SOLUTIONS LIMITED
Navi Mumbai LUPIN LIMITED
Pirangut Lupin Limited
Pithampur Lupin Limited (Unit 1)
Anakapalli District Lupin Manufacturing Solutions Limited
Pithampur Lupin Limited
Nagpur Lupin Limited
Mandideep Lupin Limited
Mumbai Lupin Limited
Mandideep Lupin Limited (Unit II)
Vasco Da Gama Lupin Limited
Aurangabad Lupin Ltd.
Tarapur, Thane Lupin Limited
Pune Lupin Bioresearch Center
United States
Coral Springs Lupin Research Inc
Baltimore Lupin Pharmaceuticals Inc.





10. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Jul 1, 2002
5MG

tablet Prescription ORAL AB Jul 1, 2002
10MG

tablet Prescription ORAL AB Jul 1, 2002
20MG

tablet Prescription ORAL AB Jul 1, 2002
30MG

tablet Prescription ORAL AB Jul 1, 2002
40MG

tablet Prescription ORAL AB Jul 1, 2002





11. RISING

Rising Pharma Holdings Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Discontinued ORAL N/A Jul 1, 2002
5MG

tablet Discontinued ORAL N/A Jul 1, 2002
10MG

tablet Discontinued ORAL N/A Jul 1, 2002
20MG

tablet Discontinued ORAL N/A Jul 1, 2002
30MG

tablet Discontinued ORAL N/A Jul 1, 2002
40MG

tablet Discontinued ORAL N/A Jul 1, 2002


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Livingston Risingsun Iodine Products Corp.
Mount Morris Rising Creek Bakery LLC
East Brunswick Rising Pharma Holding, Inc.
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Phoenix Rising Sun Farms Inc
Saddle Brook Rising Pharmaceuticals, Inc.
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Decatur Rising Pharma Holdings, Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





12. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Sep 15, 2020
10MG

tablet Prescription ORAL AB Sep 15, 2020
5MG

tablet Prescription ORAL AB Sep 15, 2020
40MG

tablet Prescription ORAL AB Mar 4, 2021
30MG

tablet Prescription ORAL AB Mar 4, 2021
20MG

tablet Prescription ORAL AB Mar 4, 2021





13. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Discontinued ORAL N/A Jul 1, 2002
5MG

tablet Discontinued ORAL N/A Jul 1, 2002
10MG

tablet Discontinued ORAL N/A Jul 1, 2002
20MG

tablet Discontinued ORAL N/A Jul 1, 2002
30MG

tablet Discontinued ORAL N/A Jul 1, 2002
40MG

tablet Discontinued ORAL N/A Jul 1, 2002


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Bangalore Strides Pharma Science Limited
Puducherry Strides Pharma Science Limited





14. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Jul 1, 2002
5MG

tablet Prescription ORAL AB Jul 1, 2002
10MG

tablet Prescription ORAL AB Jul 1, 2002
20MG

tablet Prescription ORAL AB Jul 1, 2002
40MG

tablet Prescription ORAL AB Jul 1, 2002
30MG

tablet Prescription ORAL AB Feb 11, 2003





15. TEVA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Discontinued ORAL N/A Jul 1, 2002
5MG

tablet Discontinued ORAL N/A Jul 1, 2002
10MG

tablet Discontinued ORAL N/A Jul 1, 2002
20MG

tablet Discontinued ORAL N/A Jul 1, 2002
30MG

tablet Discontinued ORAL N/A Jul 1, 2002
40MG

tablet Discontinued ORAL N/A Jul 1, 2002


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Fort Dodge TEVA Animal Health Inc
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Horsham Teva Branded Pharmaceutical Products R&D
India
Bhind Teva API India Ltd- Malanpur
Gajraula, Amroha Teva API India Private Ltd.
Canada
Stouffville Teva Canada Limited
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





16. WATSON LABS

Watson Laboratories Inc has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG

tablet Prescription ORAL AB Jul 1, 2002
5MG

tablet Prescription ORAL AB Jul 1, 2002
10MG

tablet Prescription ORAL AB Jul 1, 2002
20MG

tablet Prescription ORAL AB Jul 1, 2002
30MG

tablet Prescription ORAL AB Jul 1, 2002
40MG

tablet Prescription ORAL AB Jul 1, 2002





17. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 6 different strengths of generic version for Lisinopril. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
40MG

tablet Prescription ORAL AB Apr 19, 2007
2.5MG

tablet Prescription ORAL AB Apr 19, 2007
5MG

tablet Prescription ORAL AB Apr 19, 2007
10MG

tablet Prescription ORAL AB Apr 19, 2007
20MG

tablet Prescription ORAL AB Apr 19, 2007
30MG

tablet Prescription ORAL AB Apr 19, 2007